Sevoflurane and the feto-placental vasculature: The role of nitric oxide and vasoactive eicosanoids

Anesthesia and Analgesia

Volumn 107, Issue 1, 2008, Pages 171-177

  Farragher, Rachel ^a   Maharaj, Chrisen H ^a   Higgins, Brendan D ^a   Crowe, Sharon ^b   Burke, Padvaic ^b   Laffey, Christopher D ^b   Flynn, Noel M ^a   Laffey, John G ^a,c  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b Public Analyst Laboratory   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ICOSANOID; INDOMETACIN; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORDIHYDROGUAIARETIC ACID; SEVOFLURANE; ETHER DERIVATIVE; INHALATION ANESTHETIC AGENT; NITROPRUSSIDE SODIUM;

ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FETOPLACENTAL UNIT; FETUS CIRCULATION; GENERAL ANESTHESIA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; OBSTETRIC ANESTHESIA; PLACENTA CIRCULATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VASCULAR SMOOTH MUSCLE; VASODILATATION; FEMALE; FETUS; PHYSIOLOGY; PLACENTA; PREGNANCY; VASCULARIZATION;

ANESTHETICS, INHALATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EICOSANOIDS; FEMALE; FETUS; HUMANS; INDOMETHACIN; METHYL ETHERS; NITRIC OXIDE; NITROPRUSSIDE; NORDIHYDROGUAIARETIC ACID; OMEGA-N-METHYLARGININE; PLACENTA; PREGNANCY; VASODILATION;

EID: 49849097616     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e318173465e     Document Type: Article

References (27)

1. Schwarz U, Galinkin JL. Anesthesia for fetal surgery. Semin Pediatr Surg 2003;12:196-201
2. Gambling DR, Sharma SK, White PF, Van Beveren T, Bala AS, Gouldson R. Use of sevoflurane during elective cesarean birth: a comparison with isoflurane and spinal anesthesia. Anesth Analg 1995;81:90-5
3. Chin KJ, Yeo SW. Bispectral index values at sevoflurane concentrations of 1% and 1.5% in lower segment cesarean delivery. Anesth Analg 2004;98:1140-4
4. Chin KJ, Yeo SW. A BIS-guided study of sevoflurane requirements for adequate depth of anaesthesia in Caesarean section. Anaesthesia 2004;59:1064-8
5. Flynn NM, Kenny D, Pelc LR, Warltier DC, Bosnjak ZJ, Kamp-ine JP. Endothelium-dependent vasodilation of canine coronary collateral vessels. Am J Physiol 1991;261:H1797-801
6. Flynn N, Buljubasic N, Bosnjak ZJ, Kampine JP. Cerebral vascular responses to anesthetics. Adv Exp Med Biol 1991;301:237-46
7. Flynn NM, Buljubasic N, Bosnjak ZJ, Kampine JP. Isoflurane produces endothelium-independent relaxation in canine middle cerebral arteries. Anesthesiology 1992;76:461-7
8. 2+ increase and vasorelaxation of vascular smooth muscle in the rat aorta. Br J Anaesth 2000;84:215-20
9. Arriero MM, Munoz Alameda L, Lopez-Farre A, Escribano Burgos M, Carrasco C, Millas I, Celdran A, de la Pinta JC. Sevoflurane reduces endothelium- dependent vasorelaxation: role of superoxide anion and endothelin. Can J Anaesth 2002;49:471-6
10. Park KW, Dai HB, Lowenstein E, Sellke FW. Flow-induced dilation of rat coronary microvessels is attenuated by isoflurane but enhanced by halothane. Anesthesiology 1998;89:132-42
11. Juza M, Jakubetz H, Hettesheimer H, Schurig V. Quantitative determination of isoflurane enantiomers in blood samples during and after surgery via headspace gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 1999;735:93-102
12. Yang NC, Hwang KL, Shen CH, Wang HF, Ho WM. Simultaneous determination of fluorinated inhalation anesthetics in blood by gas chromatography-mass spectrometry combined with a headspace autosampler. J Chromatogr B Biomed Sci Appl 2001;759:307-18
13. Moir DD. Anaesthesia for Caesarean section. An evaluation of a method using low concentrations of halothane and 50 per cent of oxygen. Br J Anaesth 1970;42:136-42
14. Ducloy-Bouthors AS, Marciniak B, Vaast P, Fayoux P, Houfflin-Debarge V, Fily A, Rakza T. [Maternal and foetal anaesthesia for ex utero intrapartum treatment (EXIT) procedure]. Ann Fr Anesth Reanim 2006;25:638-43
15. Duncan PG, Pope WD, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986;64:790-4
16. Mazze RI, Kallen B. Reproductive outcome after anesthesia and operation during pregnancy: a registry study of 5405 cases. Am J Obstet Gynecol 1989;161:1178-85
17. Kort B, Katz VL, Watson WJ. The effect of nonobstetric operation during pregnancy. Surg Gynecol Obstet 1993;177:371-6
18. Reedy MB, Kallen B, Kuehl TJ. Laparoscopy during pregnancy: a study of five fetal outcome parameters with use of the Swedish Health Registry. Am J Obstet Gynecol 1997;177:673-9
19. Ong BY, Baron K, Stearns EL, Baron C, Paetkau D, Segstro R. Severe fetal bradycardia in a pregnant surgical patient despite normal oxygenation and blood pressure. Can J Anaesth 2003;50:922-5
20. Biehl DR, Yarnell R, Wade JG, Sitar D. The uptake of isoflurane by the foetal lamb in utero: effect on regional blood flow. Can Anaesth Soc J 1983;30:581-6
21. Chaudhuri G, Cuevas J, Buga GM, Ignarro LJ. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels. Am J Physiol 1993;265:H2036-43
22. 2+ regulation and NO production in human fetal venous endothelial cells. FASEB J 2002; 16:721-3
23. Kublickiene KR, Lindblom B, Kruger K, Nisell H. Preeclampsia: evidence for impaired shear stress-mediated nitric oxide release in uterine circulation. Am J Obstet Gynecol 2000;183:160-6
24. Kenny LC, Baker PN, Kendall DA, Randall MD, Dunn WR. Differential mechanisms of endothelium-dependent vasodilator responses in human myometrial small arteries in normal pregnancy and pre-eclampsia. Clin Sci (Lond) 2002;103:67-73
25. Tanaka K, Ludwig LM, Krolikowski JG, Alcindor D, Pratt PF, Kersten JR, Pagel PS, Warltier DC. Isoflurane produces delayed preconditioning against myocardial ischemia and reperfusion injury: role of cyclooxygenase-2. Anesthesiology 2004;100: 525-31
26. Heind B, Reichle F, Beckert BF. Sevoflurane but not isoflurane can reduce prostacyclin production of endothelial cells. Eur J Anaesthesiol 2003;20:116-9
27. Youngren JF, Gable K, Penaranda C, Maddux BA, Zavodovskaya M, Lobo M, Campbell M, Kerner J, Goldfine ID. Nordihydroguaiaretic acid (NDGA) inhibits the IGF-1 and c-erbB2/HER2/neu receptors and suppresses growth in breast cancer cells. Breast Cancer Res Treat 2005;94:37-46